
Activez les alertes d’offres d’emploi par e-mail !
Générez un CV personnalisé en quelques minutes
Décrochez un entretien et gagnez plus. En savoir plus
A prestigious research university in France is seeking a post-doctoral fellow in biochemical pharmacology for the Cancer Drug Research Laboratory. The role involves characterizing cell signaling in response to anti-cancer treatments and conducting various biochemical assays. Candidates should possess a PhD in molecular biology, biochemistry, or pharmacology, ideally within 5 years of graduation. This position offers a full-time temporary contract.
Organisation/Company McGill University Research Field Biological sciences » Biology Chemistry » Biochemistry Biological sciences » Biology Researcher Profile First Stage Researcher (R1) Country France Application Deadline 26 Dec 2025 - 22:00 (UTC) Type of Contract Temporary Job Status Full-time Is the job funded through the EU Research Framework Programme? Not funded by a EU programme Is the Job related to staff position within a Research Infrastructure? No
Applications are invited for a post-doctoral fellowship in biochemical pharmacology in the Cancer Drug Research Laboratory, The Research Institute of McGill University. The successful candidate will be involved in the characterization of cell signaling cascades in response to anti-cancer drug treatment using western blot analysis and other biochemical assays. Knowledge of immunology, DNA sequencing (WES, RNAseq) and experience with animal models is an asset.
According to McGill University Post-Graduate policies, eligible post-doctoral candidates must be within 5 years after their Ph.D. degree.
Preference will be given to candidates with a PhD in molecular biology, biochemistry or pharmacology.